Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Change in Accured Expenses (2019 - 2025)

Revolution Medicines has reported Change in Accured Expenses over the past 7 years, most recently at $54.6 million for Q4 2025.

  • Quarterly results put Change in Accured Expenses at $54.6 million for Q4 2025, up 198.42% from a year ago — trailing twelve months through Dec 2025 was $112.3 million (up 410.65% YoY), and the annual figure for FY2025 was $112.3 million, up 410.65%.
  • Change in Accured Expenses for Q4 2025 was $54.6 million at Revolution Medicines, up from $45.3 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for RVMD hit a ceiling of $54.6 million in Q4 2025 and a floor of -$21.3 million in Q1 2024.
  • Median Change in Accured Expenses over the past 5 years was $2.9 million (2021), compared with a mean of $8.0 million.
  • Biggest five-year swings in Change in Accured Expenses: surged 2059.69% in 2021 and later plummeted 1113.41% in 2024.
  • Revolution Medicines' Change in Accured Expenses stood at $3.7 million in 2021, then tumbled by 179.24% to -$3.0 million in 2022, then plummeted by 112.1% to -$6.3 million in 2023, then skyrocketed by 390.86% to $18.3 million in 2024, then skyrocketed by 198.42% to $54.6 million in 2025.
  • The last three reported values for Change in Accured Expenses were $54.6 million (Q4 2025), $45.3 million (Q3 2025), and $10.8 million (Q2 2025) per Business Quant data.